Latest News about SLN
Recent news which mentions SLN
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
February 11, 2025
From Benzinga
Top 3 Health Care Stocks That May Explode In Q4
December 18, 2024
From Benzinga
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Top 3 Health Care Stocks You'll Regret Missing In Q4
November 19, 2024
From Benzinga
Tickers
SLN
From InvestorPlace
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
From InvestorPlace
From InvestorPlace
Tickers
SLN
From InvestorPlace
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
April 11, 2024
From InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
From InvestorPlace
These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results
March 14, 2024
From Benzinga
What's Going On With Silence Therapeutics Stock Today?
March 13, 2024
From Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
From Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
From Benzinga
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
January 31, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
From Benzinga
Is This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease Candidate
November 01, 2023
Tickers
SLN
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 01, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.